410 related articles for article (PubMed ID: 29880781)
1. Inhibition and Inactivation of Uropathogenic
Narayanan A; Nair MS; Muyyarikkandy MS; Amalaradjou MA
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29880781
[TBL] [Abstract][Full Text] [Related]
2. Synergistic cranberry juice combinations with natural-borne antimicrobials for the eradication of uropathogenic Escherichia coli biofilm within a short time.
Kim HW; Chung DH; Kim SA; Rhee MS
Lett Appl Microbiol; 2019 Apr; 68(4):321-328. PubMed ID: 30801748
[TBL] [Abstract][Full Text] [Related]
3. Antibiofilm effect of trans-cinnamaldehyde on uropathogenic Escherichia coli.
Amalaradjou MA; Narayanan A; Baskaran SA; Venkitanarayanan K
J Urol; 2010 Jul; 184(1):358-63. PubMed ID: 20488489
[TBL] [Abstract][Full Text] [Related]
4. Carvacrol-rich oregano oil and thymol-rich thyme red oil inhibit biofilm formation and the virulence of uropathogenic Escherichia coli.
Lee JH; Kim YG; Lee J
J Appl Microbiol; 2017 Dec; 123(6):1420-1428. PubMed ID: 28980415
[TBL] [Abstract][Full Text] [Related]
5. Effect of different antibiotics on biofilm produced by uropathogenic Escherichia coli isolated from children with urinary tract infection.
González MJ; Robino L; Iribarnegaray V; Zunino P; Scavone P
Pathog Dis; 2017 Jun; 75(4):. PubMed ID: 28505288
[TBL] [Abstract][Full Text] [Related]
6. Synergistic mode of action of catechin, vanillic and protocatechuic acids to inhibit the adhesion of uropathogenic Escherichia coli on silicone surfaces.
Bernal-Mercado AT; Gutierrez-Pacheco MM; Encinas-Basurto D; Mata-Haro V; Lopez-Zavala AA; Islas-Osuna MA; Gonzalez-Aguilar GA; Ayala-Zavala JF
J Appl Microbiol; 2020 Feb; 128(2):387-400. PubMed ID: 31573730
[TBL] [Abstract][Full Text] [Related]
7. Carbon monoxide releasing molecule-2 (CORM-2) inhibits growth of multidrug-resistant uropathogenic Escherichia coli in biofilm and following host cell colonization.
Sahlberg Bang C; Kruse R; Johansson K; Persson K
BMC Microbiol; 2016 Apr; 16():64. PubMed ID: 27067266
[TBL] [Abstract][Full Text] [Related]
8. A systematic review and meta-analysis of antibiotic resistance patterns, and the correlation between biofilm formation with virulence factors in uropathogenic E. coli isolated from urinary tract infections.
Zhao F; Yang H; Bi D; Khaledi A; Qiao M
Microb Pathog; 2020 Jul; 144():104196. PubMed ID: 32283258
[TBL] [Abstract][Full Text] [Related]
9. Biofilm Formation by Uropathogenic Escherichia coli Is Favored under Oxygen Conditions That Mimic the Bladder Environment.
Eberly AR; Floyd KA; Beebout CJ; Colling SJ; Fitzgerald MJ; Stratton CW; Schmitz JE; Hadjifrangiskou M
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28973965
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice.
Guiton PS; Cusumano CK; Kline KA; Dodson KW; Han Z; Janetka JW; Henderson JP; Caparon MG; Hultgren SJ
Antimicrob Agents Chemother; 2012 Sep; 56(9):4738-45. PubMed ID: 22733070
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive phenotypic and genotypic characterization and comparison of virulence, biofilm, and antimicrobial resistance in urinary Escherichia coli isolated from canines.
Gilbertie JM; Levent G; Norman KN; Vinasco J; Scott HM; Jacob ME
Vet Microbiol; 2020 Oct; 249():108822. PubMed ID: 32937249
[TBL] [Abstract][Full Text] [Related]
12. Suppressing the phenotypic virulence factors of Uropathogenic Escherichia coli using marine polysaccharide.
Rubini D; Varthan PV; Jayasankari S; Vedahari BN; Nithyanand P
Microb Pathog; 2020 Apr; 141():103973. PubMed ID: 31927002
[TBL] [Abstract][Full Text] [Related]
13. Biosynthesis of silver nanoparticles by Fusarium scirpi and its potential as antimicrobial agent against uropathogenic Escherichia coli biofilms.
Rodríguez-Serrano C; Guzmán-Moreno J; Ángeles-Chávez C; Rodríguez-González V; Ortega-Sigala JJ; Ramírez-Santoyo RM; Vidales-Rodríguez LE
PLoS One; 2020; 15(3):e0230275. PubMed ID: 32163495
[TBL] [Abstract][Full Text] [Related]
14. Luteolin decreases the attachment, invasion and cytotoxicity of UPEC in bladder epithelial cells and inhibits UPEC biofilm formation.
Shen XF; Ren LB; Teng Y; Zheng S; Yang XL; Guo XJ; Wang XY; Sha KH; Li N; Xu GY; Tian HW; Wang XY; Liu XK; Li J; Huang N
Food Chem Toxicol; 2014 Oct; 72():204-11. PubMed ID: 25051393
[TBL] [Abstract][Full Text] [Related]
15. Fosfomycin tromethamine activity on biofilm and intracellular bacterial communities produced by uropathogenic Escherichia coli isolated from patients with urinary tract infection.
González MJ; Da Cunda P; Notejane M; Zunino P; Scavone P; Robino L
Pathog Dis; 2019 Apr; 77(3):. PubMed ID: 31062019
[TBL] [Abstract][Full Text] [Related]
16. Outcome of acute urinary tract infections caused by uropathogenic
Pullanhi U; Khan S; Vinod V; Mohan K; Kumar A
Ann Afr Med; 2019; 18(3):138-142. PubMed ID: 31417014
[TBL] [Abstract][Full Text] [Related]
17. Phylogenetic Group B2 Expressed Significant Biofilm Formation among Drug Resistant Uropathogenic Escherichia coli.
Javed S; Mirani ZA; Pirzada ZA
Libyan J Med; 2021 Dec; 16(1):1845444. PubMed ID: 33170767
[TBL] [Abstract][Full Text] [Related]
18. Characterization and zoonotic potential of uropathogenic Escherichia coli isolated from dogs.
Nam EH; Ko S; Chae JS; Hwang CY
J Microbiol Biotechnol; 2013 Mar; 23(3):422-9. PubMed ID: 23462017
[TBL] [Abstract][Full Text] [Related]
19. Biofilm and multidrug resistance in uropathogenic Escherichia coli.
Mittal S; Sharma M; Chaudhary U
Pathog Glob Health; 2015 Feb; 109(1):26-9. PubMed ID: 25605466
[TBL] [Abstract][Full Text] [Related]
20. Disperse red 15 (DR15) impedes biofilm formation of uropathogenic Escherichia coli.
Miryala S; Makala H; Yadavali SP; Venkatasubramanian U; Subbaiah N; Srinandan CS
Microb Pathog; 2020 Jan; 138():103772. PubMed ID: 31589910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
